DK1339407T3 - Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom - Google Patents

Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK1339407T3
DK1339407T3 DK01998349T DK01998349T DK1339407T3 DK 1339407 T3 DK1339407 T3 DK 1339407T3 DK 01998349 T DK01998349 T DK 01998349T DK 01998349 T DK01998349 T DK 01998349T DK 1339407 T3 DK1339407 T3 DK 1339407T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory bowel
bowel disease
protein transferase
transferase inhibitors
Prior art date
Application number
DK01998349T
Other languages
English (en)
Inventor
Charles Ronald Bowden
David William End
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1339407T3 publication Critical patent/DK1339407T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK01998349T 2000-11-28 2001-11-20 Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom DK1339407T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25334600P 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
DK1339407T3 true DK1339407T3 (da) 2006-08-14

Family

ID=22959893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01998349T DK1339407T3 (da) 2000-11-28 2001-11-20 Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom

Country Status (11)

Country Link
US (1) US20040044032A1 (da)
EP (1) EP1339407B1 (da)
JP (1) JP4231691B2 (da)
AT (1) ATE323490T1 (da)
AU (1) AU2002218311A1 (da)
CY (1) CY1106122T1 (da)
DE (1) DE60118953T2 (da)
DK (1) DK1339407T3 (da)
ES (1) ES2261523T3 (da)
PT (1) PT1339407E (da)
WO (1) WO2002043733A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272722A1 (en) * 2004-03-18 2005-12-08 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20060106060A1 (en) * 2004-03-18 2006-05-18 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies (Lansbury)
US20070293539A1 (en) * 2004-03-18 2007-12-20 Lansbury Peter T Methods for the treatment of synucleinopathies
US20050288298A1 (en) * 2004-03-18 2005-12-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
EP1744751A4 (en) * 2004-03-18 2010-03-10 Brigham & Womens Hospital TREATMENT OF SYNUCLEINOPATHIES
DK1815247T3 (da) 2004-11-05 2013-03-11 Janssen Pharmaceutica Nv Terapeutisk anvendelse af farnesyltransferaseinhibitorer og fremgangsmåder til overvågning af deres effektivitet
CA2634598A1 (en) 2005-12-23 2007-07-05 Link Medicine Corporation Treatment of synucleinopathies
US8232402B2 (en) * 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
CA2743717A1 (en) * 2008-11-13 2010-05-20 Link Medicine Corporation Azaquinolinone derivatives and uses thereof
US20100331363A1 (en) * 2008-11-13 2010-12-30 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
US20110060005A1 (en) * 2008-11-13 2011-03-10 Link Medicine Corporation Treatment of mitochondrial disorders using a farnesyl transferase inhibitor
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
CA2888210C (en) 2012-10-16 2021-02-09 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
AU2013331505A1 (en) 2012-10-16 2015-04-30 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ROR-gamma-t
JP6423423B2 (ja) 2013-10-15 2018-11-14 ヤンセン ファーマシューティカ エヌ．ベー． Ｒｏｒγｔのアルキル結合キノリニルモジュレーター
EP3057422B1 (en) 2013-10-15 2019-05-15 Janssen Pharmaceutica NV Quinolinyl modulators of ror(gamma)t
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
CA2985123C (en) 2015-08-17 2021-04-13 Antonio Gualberto Methods of treating cancer patients with farnesyltransferase inhibitors
MY190861A (en) 2016-11-03 2022-05-12 Kura Oncology Inc Farnesyltransferase inhibitors for use in methods of treating cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007498A1 (en) * 1992-10-07 1994-04-14 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical composition for inhibiting tumor necrosis factor production
US5470832A (en) * 1994-01-31 1995-11-28 Merck & Co., Inc. Inhibitors of geranylgeranyl-protein transferase
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
TW316902B (da) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
DE69620445T2 (de) * 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
US6011029A (en) * 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
US5929077A (en) * 1996-11-08 1999-07-27 Leftheris; Katerina Thioproline-containing inhibitors of farnesyl protein transferase
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
GB2323783A (en) * 1997-04-02 1998-10-07 Ferring Bv Group Holdings Inhibitors of farnesyl protein transferase
EP0977750B1 (en) * 1997-04-25 2007-07-04 Janssen Pharmaceutica N.V. Farnesyltransferase inhibiting quinazolinones
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
WO1999026657A1 (en) * 1997-11-25 1999-06-03 Musc Foundation For Research Development Inhibitors of nitric oxide synthase
TW531533B (en) * 1998-12-23 2003-05-11 Janssen Pharmaceutica Nv 1,2-annelated quinoline derivatives having farnesyl transferase and geranylgeranyl transferase inhibiting activity

Also Published As

Publication number Publication date
ATE323490T1 (de) 2006-05-15
DE60118953D1 (de) 2006-05-24
EP1339407B1 (en) 2006-04-19
JP2004514695A (ja) 2004-05-20
EP1339407A1 (en) 2003-09-03
DE60118953T2 (de) 2007-01-11
US20040044032A1 (en) 2004-03-04
ES2261523T3 (es) 2006-11-16
CY1106122T1 (el) 2011-06-08
WO2002043733A1 (en) 2002-06-06
AU2002218311A1 (en) 2002-06-11
PT1339407E (pt) 2006-08-31
JP4231691B2 (ja) 2009-03-04

Similar Documents

Publication Publication Date Title
DK1339407T3 (da) Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom
CY1105477T1 (el) Αναστολεις τρανσφepασης φαρνεσυλ πρωτεϊνης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
EA200802213A1 (ru) Способы лечения заболеваний крови
DK1094815T3 (da) Farnesylproteintransferaseinhibitorer til behandling af arthropatier
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
SE9800836D0 (sv) New Compounds
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DK1456380T3 (da) SMAD7-inhibitorer til behandling af CNS-sygdomme
SE9901077D0 (sv) Novel use
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
ATE443044T1 (de) Tace inhibitoren
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DK1339695T3 (da) Farnesyltransferase-inhibitorer
SE0004827D0 (sv) Therapeutic compounds
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
DK1513529T3 (da) Tredobbelte monoamin-genoptagelsesinhibitorer til behandling af kronisk smerte
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
EA200600115A1 (ru) Производные 2-аминобензойной кислоты